These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 16329185)

  • 1. Transcriptional regulation of NK cell receptors.
    Anderson SK
    Curr Top Microbiol Immunol; 2006; 298():59-75. PubMed ID: 16329185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of class I major histocompatibility complex receptor expression in natural killer cells: one promoter is not enough!
    Pascal V; Stulberg MJ; Anderson SK
    Immunol Rev; 2006 Dec; 214():9-21. PubMed ID: 17100872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genomic Ly49A transgenes: basis of variegated Ly49A gene expression and identification of a critical regulatory element.
    Tanamachi DM; Moniot DC; Cado D; Liu SD; Hsia JK; Raulet DH
    J Immunol; 2004 Jan; 172(2):1074-82. PubMed ID: 14707081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acquisition of MHC-specific receptors on murine natural killer cells.
    Veinotte LL; Wilhelm BT; Mager DL; Takei F
    Crit Rev Immunol; 2003; 23(4):251-66. PubMed ID: 14700270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ly49 and CD94/NKG2: developmentally regulated expression and evolution.
    Takei F; McQueen KL; Maeda M; Wilhelm BT; Lohwasser S; Lian RH; Mager DL
    Immunol Rev; 2001 Jun; 181():90-103. PubMed ID: 11513155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clonal analysis of NK cell development from bone marrow progenitors in vitro: orderly acquisition of receptor gene expression.
    Williams NS; Kubota A; Bennett M; Kumar V; Takei F
    Eur J Immunol; 2000 Jul; 30(7):2074-82. PubMed ID: 10940897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implications of CD94 deficiency and monoallelic NKG2A expression for natural killer cell development and repertoire formation.
    Vance RE; Jamieson AM; Cado D; Raulet DH
    Proc Natl Acad Sci U S A; 2002 Jan; 99(2):868-73. PubMed ID: 11782535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for epigenetic maintenance of Ly49a monoallelic gene expression.
    Rouhi A; Gagnier L; Takei F; Mager DL
    J Immunol; 2006 Mar; 176(5):2991-9. PubMed ID: 16493057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bidirectional promoters regulate the monoallelically expressed Ly49 NK receptors.
    Ensminger AW; Chess A
    Immunity; 2004 Jul; 21(1):2-3. PubMed ID: 15345214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diversity of NK cell receptor repertoire in adult and neonatal mice.
    Kubota A; Kubota S; Lohwasser S; Mager DL; Takei F
    J Immunol; 1999 Jul; 163(1):212-6. PubMed ID: 10384118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NF-kappa B p50/p65 affects the frequency of Ly49 gene expression by NK cells.
    Pascal V; Nathan NR; Claudio E; Siebenlist U; Anderson SK
    J Immunol; 2007 Aug; 179(3):1751-9. PubMed ID: 17641041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The repertoire of killer cell Ig-like receptor and CD94:NKG2A receptors in T cells: clones sharing identical alpha beta TCR rearrangement express highly diverse killer cell Ig-like receptor patterns.
    Uhrberg M; Valiante NM; Young NT; Lanier LL; Phillips JH; Parham P
    J Immunol; 2001 Mar; 166(6):3923-32. PubMed ID: 11238637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An allele-specific, stochastic gene expression process controls the expression of multiple Ly49 family genes and generates a diverse, MHC-specific NK cell receptor repertoire.
    Held W; Kunz B
    Eur J Immunol; 1998 Aug; 28(8):2407-16. PubMed ID: 9710218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NK cells developing in vitro from fetal mouse progenitors express at least one member of the Ly49 family that is acquired in a time-dependent and stochastic manner independently of CD94 and NKG2.
    Fraser KP; Gays F; Robinson JH; van Beneden K; Leclercq G; Vance RE; Raulet DH; Brooks CG
    Eur J Immunol; 2002 Mar; 32(3):868-78. PubMed ID: 11870631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of probabilistic transcriptional switches in the Ly49 gene cluster: a eukaryotic mechanism for selective gene activation.
    Saleh A; Davies GE; Pascal V; Wright PW; Hodge DL; Cho EH; Lockett SJ; Abshari M; Anderson SK
    Immunity; 2004 Jul; 21(1):55-66. PubMed ID: 15345220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ly49 and CD94/NKG2 receptor acquisition by NK cells does not require lymphotoxin-beta receptor expression.
    Stevenaert F; Van Beneden K; De Colvenaer V; Franki AS; Debacker V; Boterberg T; Deforce D; Pfeffer K; Plum J; Elewaut D; Leclercq G
    Blood; 2005 Aug; 106(3):956-62. PubMed ID: 15827137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of Ly49E and CD94/NKG2 on fetal and adult NK cells.
    Van Beneden K; Stevenaert F; De Creus A; Debacker V; De Boever J; Plum J; Leclercq G
    J Immunol; 2001 Apr; 166(7):4302-11. PubMed ID: 11254682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct binding of purified HLA class I antigens by soluble NKG2/CD94 C-type lectins from natural killer cells.
    Ding Y; Sumitran S; Holgersson J
    Scand J Immunol; 1999 May; 49(5):459-65. PubMed ID: 10320637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of natural killer cell function.
    Makrigiannis AP; Anderson SK
    Cancer Biol Ther; 2003; 2(6):610-6. PubMed ID: 14688463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural killer cell receptors in the horse: evidence for the existence of multiple transcribed LY49 genes.
    Takahashi T; Yawata M; Raudsepp T; Lear TL; Chowdhary BP; Antczak DF; Kasahara M
    Eur J Immunol; 2004 Mar; 34(3):773-784. PubMed ID: 14991607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.